Japan Eyes Cutting Reimbursement For COVID-19 Drugs

Large Reduction For Xocova?

 
• By Lisa Takagi
  
Balancing NHI system and the market’s demand for accessible drugs for COVID-19 can be a challenging task.
Japan's challenge to balance NHI system and market demand for COVID-19 drugs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia